NBOMes - Revision history

Dread: Changed dosage table to use api

2019-04-02T16:33:08Z

Changed dosage table to use api

@@ Line 12: / Line 12: @@
 === 25B-NBOMe ===
-{| class="wikitable"
+{{#tdose: 25B-NBOMe}}
 === 25C-NBOMe ===

GrimReaper at 06:52, 11 March 2015

2015-03-11T06:52:25Z

← Older revision		Revision as of 01:52, 11 March 2015
Line 3:		Line 3:
	These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's strongly recommended to not take more than 1500 µg of any substance of the NBOMe family, as there have been multiple deaths from people taking just 2-3 blotters.		These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's strongly recommended to not take more than 1500 µg of any substance of the NBOMe family, as there have been multiple deaths from people taking just 2-3 blotters.

	= ~~Doses~~ =		== Dosage ==
	Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.		Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.

Line 10:		Line 10:
	The doses of NBOMes remain a controversial subject, as deaths have been reported at doses that were previously assumed acceptable. Please use caution, and in any case, '''do not exceed 1500µg'''!		The doses of NBOMes remain a controversial subject, as deaths have been reported at doses that were previously assumed acceptable. Please use caution, and in any case, '''do not exceed 1500µg'''!

	== 25B-NBOMe ==		=== 25B-NBOMe ===

	{\| class="wikitable"		{\| class="wikitable"
Line 32:		Line 32:
	\|}		\|}

	== 25C-NBOMe ==		=== 25C-NBOMe ===

	{\| class="wikitable"		{\| class="wikitable"
Line 44:		Line 44:
	\|}		\|}

	== 25I-NBOMe ==		=== 25I-NBOMe ===

	{\| class="wikitable"		{\| class="wikitable"
Line 66:		Line 66:
	\|}		\|}

	= Duration =		== Duration ==

	{\| class="wikitable"		{\| class="wikitable"
Line 84:		Line 84:
	\|}		\|}

	= Effects =		== Effects ==

	== Positive ==		=== Positive ===

	* Strong open and closed eye visuals, including trails, color shifts, brightening, etc.		* Strong open and closed eye visuals, including trails, color shifts, brightening, etc.
Line 98:		Line 98:
	* Feelings of love and empathy		* Feelings of love and empathy

	== Neutral ==		=== Neutral ===

	* General change in consciousness		* General change in consciousness
Line 108:		Line 108:
	* Yawning, especially when coming up		* Yawning, especially when coming up

	== Negative ==		=== Negative ===

	Likelihood of negative side effects increases with higher doses.		Likelihood of negative side effects increases with higher doses.
Line 122:		Line 122:
	* Unwanted life-changing spiritual experiences		* Unwanted life-changing spiritual experiences

	== After effects ==		=== After effects ===

	* Afterglow		* Afterglow
Line 130:		Line 130:
	**A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.		**A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.

	= Harm Reduction =		== Harm Reduction ==

	NBOMes are considered less safe than many psychedelics due their heavy physical effects on the body, and as recreational dosages tend to overlap with what have been fatal dosages. Even so, many reports of death by an NBOMe chemical involve mislabeling of the drug, sometimes by the distributor (example: someone insufflates 20mg of 25I-NBOMe because he/she thought it was 2C-I). Mislabeling or misweighing can easily lead to extrememely dangerous, sometimes lethal, situations. Administration of an NBOMe in its powder form (either insufflated or otherwise) is strongly discouraged, as the potency is far greater than the accuracy of most scales.		NBOMes are considered less safe than many psychedelics due their heavy physical effects on the body, and as recreational dosages tend to overlap with what have been fatal dosages. Even so, many reports of death by an NBOMe chemical involve mislabeling of the drug, sometimes by the distributor (example: someone insufflates 20mg of 25I-NBOMe because he/she thought it was 2C-I). Mislabeling or misweighing can easily lead to extrememely dangerous, sometimes lethal, situations. Administration of an NBOMe in its powder form (either insufflated or otherwise) is strongly discouraged, as the potency is far greater than the accuracy of most scales.
Line 138:		Line 138:
	See [[Psychedelics#Harm_Reduction\|Psychedelic Harm Reduction]] for general information.		See [[Psychedelics#Harm_Reduction\|Psychedelic Harm Reduction]] for general information.

	= ~~Legal status~~ =		== Images ==

	== Europe ==		<gallery mode="packed-hover" heights="150px">
			Image:25b.jpg\|''25B-NBOMe''
			Image:25c.jpg\|''25C-NBOMe''
			Image:25i.jpg\|''25I-NBOMe''
			</gallery>


			== Legal status ==

			=== Europe ===

	The NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011.<ref>http://www.rg.ru/2011/10/19/narko-dok.html</ref>		The NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011.<ref>http://www.rg.ru/2011/10/19/narko-dok.html</ref>
Line 146:		Line 155:
	The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.<ref>http://www.legislation.gov.uk/ukdsi/2014/9780111110904</ref>		The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.<ref>http://www.legislation.gov.uk/ukdsi/2014/9780111110904</ref>

	== America ==		=== America ===

	25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref>		25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref>

	= ~~Images~~ =		== Links ==

	~~<gallery mode="packed-hover" heights="150px">~~
	~~Image:25b.jpg\|''25B-NBOMe''~~
	~~Image:25c.jpg\|''25C-NBOMe''~~
	~~Image:25i.jpg\|''25I-NBOMe''~~
	~~</gallery>~~

	= ~~Links~~ =

	[https://en.wikipedia.org/wiki/NBOMe Wikipedia]		[https://en.wikipedia.org/wiki/NBOMe Wikipedia]
Line 166:		Line 167:
	[http://www.reddit.com/r/Drugs/comments/14wua3/rdrugs_faq_series_nbome_series_aka_25xnbome/?sort=top /r/Drugs FAQ]		[http://www.reddit.com/r/Drugs/comments/14wua3/rdrugs_faq_series_nbome_series_aka_25xnbome/?sort=top /r/Drugs FAQ]

	= References =		== References ==

	<references />		<references />

Sleep at 20:33, 23 December 2014

2014-12-23T20:33:15Z

← Older revision		Revision as of 15:33, 23 December 2014
Line 172:		Line 172:
	[[Category:Psychedelic]]		[[Category:Psychedelic]]
	[[Category:Drugs]]		[[Category:Drugs]]
			[[Category:Research Chemical]]

Sevenforall: /* 25I-NBOMe */

2014-10-14T23:38:05Z

25I-NBOMe

← Older revision		Revision as of 18:38, 14 October 2014
Line 55:		Line 55:
	\| Strong \|\| 700-1000+ μg		\| Strong \|\| 700-1000+ μg
	\|}		\|}

	~~'''Do not exceed 1500µg!'''~~

	{\| class="wikitable"		{\| class="wikitable"

Sevenforall: /* 25I-NBOMe */

2014-10-14T23:37:42Z

25I-NBOMe

← Older revision		Revision as of 18:37, 14 October 2014
Line 51:		Line 51:
	\| Light \|\| 200-500 μg		\| Light \|\| 200-500 μg
	\|-		\|-
	\| Common \|\| 500-~~1000~~ μg		\| Common \|\| 500-750 μg
	\|-		\|-
	\| Strong \|\| 1000~~-1500~~ μg		\| Strong \|\| 700-1000+ μg
	\|}		\|}

			'''Do not exceed 1500µg!'''

	{\| class="wikitable"		{\| class="wikitable"

Sevenforall: /* 25I-NBOMe */

2014-10-14T23:36:40Z

25I-NBOMe

← Older revision		Revision as of 18:36, 14 October 2014
Line 53:		Line 53:
	\| Common \|\| 500-1000 μg		\| Common \|\| 500-1000 μg
	\|-		\|-
	\| Strong \|\| 1500+ μg		\| Strong \|\| 1000-1500 μg
	\|}		\|}

Sevenforall at 23:36, 14 October 2014

2014-10-14T23:36:03Z

← Older revision		Revision as of 18:36, 14 October 2014
Line 1:		Line 1:
	[[File:25c.jpg\|thumb\|300px\|25C-NBOMe tabs dosed at 1mg each.]]		[[File:25c.jpg\|thumb\|300px\|25C-NBOMe tabs dosed at 1mg each.]]

	These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's recommended to not take more than ~~1.5 mg~~ of any substance of the NBOMe family, as there have been multiple deaths from people just ~~taking~~ 2-3 blotters.		These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's strongly recommended to not take more than 1500 µg of any substance of the NBOMe family, as there have been multiple deaths from people taking just 2-3 blotters.

	= Doses =		= Doses =

Sevenforall: /* 25I-NBOMe */

2014-10-14T23:35:01Z

25I-NBOMe

← Older revision		Revision as of 18:35, 14 October 2014
Line 51:		Line 51:
	\| Light \|\| 200-500 μg		\| Light \|\| 200-500 μg
	\|-		\|-
	\| Common \|\| 500-~~1500~~ μg		\| Common \|\| 500-1000 μg
	\|-		\|-
	\| Strong \|\| 1500+ μg		\| Strong \|\| 1500+ μg
Line 63:		Line 63:
	\| Common \|\| 400-700 μg		\| Common \|\| 400-700 μg
	\|-		\|-
	\| Strong \|\| 700+ μg+		\| Strong \|\| 700+ μg
	\|}		\|}

Sevenforall: /* Dosages */

2014-10-14T23:32:34Z

Dosages

← Older revision		Revision as of 18:32, 14 October 2014
Line 3:		Line 3:
	These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's recommended to not take more than 1.5 mg of any substance of the NBOMe family, as there have been multiple deaths from people just taking 2-3 blotters.		These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's recommended to not take more than 1.5 mg of any substance of the NBOMe family, as there have been multiple deaths from people just taking 2-3 blotters.

	= ~~Dosages~~ =		= Doses =
	Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.		Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.

	NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral bioavailability of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.		NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral bioavailability of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.

	== ~~25I~~-NBOMe ==		The doses of NBOMes remain a controversial subject, as deaths have been reported at doses that were previously assumed acceptable. Please use caution, and in any case, '''do not exceed 1500µg'''!

			== 25B-NBOMe ==

	{\| class="wikitable"		{\| class="wikitable"
	\|+ Sublingual		\|+ Sublingual
	\|-		\|-
	\| Light \|\| ~~200~~-~~500~~ μg		\| Light \|\| 100-300 μg
	\|-		\|-
	\| Common \|\| 500~~-1500~~ μg		\| Common \|\| 300-500 μg
	\|-		\|-
	\| Strong \|\| ~~1500~~+ μg		\| Strong \|\| 500-700+ μg
	\|}		\|}

Line 23:		Line 25:
	\|+ Insufflated		\|+ Insufflated
	\|-		\|-
	\| Light \|\| ~~100~~-~~400~~ μg		\| Light \|\| 50-200 μg
	\|-		\|-
	\| Common \|\| ~~400~~-~~700~~ μg		\| Common \|\| 200-350 μg
	\|-		\|-
	\| Strong \|\| ~~700~~+ μg+		\| Strong \|\| 350-500+ μg
	\|}		\|}

Line 42:		Line 44:
	\|}		\|}

	== ~~25B~~-NBOMe ==		== 25I-NBOMe ==

	{\| class="wikitable"		{\| class="wikitable"
	\|+ Sublingual		\|+ Sublingual
	\|-		\|-
	\| Light \|\| ~~100~~-~~300~~ μg		\| Light \|\| 200-500 μg
	\|-		\|-
	\| Common \|\| ~~300~~-~~500~~ μg		\| Common \|\| 500-1500 μg
	\|-		\|-
	\| Strong \|\| ~~500-700~~+ μg		\| Strong \|\| 1500+ μg
	\|}		\|}

Line 57:		Line 59:
	\|+ Insufflated		\|+ Insufflated
	\|-		\|-
	\| Light \|\| 50-~~200~~ μg		\| Light \|\| 100-400 μg
	\|-		\|-
	\| Common \|\| ~~200~~-~~350~~ μg		\| Common \|\| 400-700 μg
	\|-		\|-
	\| Strong \|\| ~~350-500~~+ μg		\| Strong \|\| 700+ μg+
	\|}		\|}

Sevenforall: /* Dosages */

2014-10-14T23:17:26Z

Dosages

← Older revision		Revision as of 18:17, 14 October 2014
Line 6:		Line 6:
	Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.		Effects have been reported to vary wildly between people (example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). Drugs affect all users differently, but this unusually wide range of reported effects is down, in part, to users being unable to accurately distinguish between members of the NBOMe series, and misrepresentation of doses - a single tab regularly yields between 500ug and 2000ug of the substance.

	NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral ~~availability~~ of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.		NBOMes were initially thought to be orally inactive, meaning they wouldn't work if swallowed. However, this is not the case for all NBOMes per se; certain NBOMe salts do have an observed oral bioavailability, with little known about the oral bioavailability of NBOMes in their freebase form. Therefore, when a substance might be an NBOMe, discard the blotter entirely rather than swallowing it, if you do not wish to risk being under the influence of an NBOMe. Oral administration is relatively uncommon and thus undocumented, presumably as a result of the existing confusion about the oral bioavailability of NBOMes. Sublingual administration is the most common, but buccal administration is recommended if you wish to avoid the generally bitter taste of NBOMes.

	== 25I-NBOMe ==		== 25I-NBOMe ==